Grant: Fellowship - Priority Announcement: Gastroenterology
University of British Columbia
$45,000.00
Transformation of the human cell protein landscape by Enteropathogenic and Enterohemorrhagic Escherichia coli during infection by rewiring host phosphorylation signalling
FY 2016-17
Summary
Diarrheal disease affects 1.7 billion people every year, killing around 760 000 children. A leading cause of this are the "attaching-and-effacing" (A/E) pathogens, including enteropathogenic (EPEC) and enterohemorrhagic Escherichia coli (EHEC - the agent of "hamburger disease"). EPEC and EHEC's ability to cause disease relies on manipulating the human gut in order to create an environment where they can thrive. They achieve this by secreting "effector" proteins directly into host cells using a sophisticated molecular syringe. These effectors then manipulate host signalling proteins to take control of processes like gut cell survival and immune signalling away from the host. One way in which effectors achieve this is by altering how chemical phosphate groups are added to host signaling proteins. EPEC and EHEC also secrete a number of phosphorylating effectors (kinases) into host cells, which may have redundant or even antagonistic functions. The role of phosphorylation in disease is poorly understood, but in many other systems regulates how proteins interact.
I propose to show that EPEC's ability to manipulate phosphorylation of host proteins triggers dramatic changes in the way they behave and bind to each other, and that this is essential to infection. I first will use a newly developed technique to identify which host proteins are specifically phosphorylated by the effectors of EPEC, and which are phosphorylated as a general consequence of infection. I will then monitor how the interaction partnerships that host proteins participate in change as a consequence of this phosphorylation. Finally, I will investigate whether interfering in these EPEC-manipulation of host protein interaction blocks infection. This will be the first ever whole cell host-pathogen "interactome" study, and will develop a methodology for studying host-pathogen relationships, aiding development of better antibiotics in an age of increasing bacterial resistance.
Department
Program
Fellowship - Priority Announcement: Gastroenterology
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
363800
Name
McCoy James M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Transformation of the human cell protein landscape by Enteropathogenic and Enterohemorrhagic Escherichia coli during infection by rewiring host phosphorylation signalling
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Gastroenterology
Keyworddelim
Attaching And Effacing Pathogens; Bacteria; Cell Signalling; Effector Proteins; Host-Pathogen Interaction; Intestinal Pathogens; Phosphorylation; Protein-Protein Interaction; Proteomics
Abstract
Diarrheal disease affects 1.7 billion people every year, killing around 760 000 children. A leading cause of this are the "attaching-and-effacing" (A/E) pathogens, including enteropathogenic (EPEC) and enterohemorrhagic Escherichia coli (EHEC - the agent of "hamburger disease"). EPEC and EHEC's ability to cause disease relies on manipulating the human gut in order to create an environment where they can thrive. They achieve this by secreting "effector" proteins directly into host cells using a sophisticated molecular syringe. These effectors then manipulate host signalling proteins to take control of processes like gut cell survival and immune signalling away from the host. One way in which effectors achieve this is by altering how chemical phosphate groups are added to host signaling proteins. EPEC and EHEC also secrete a number of phosphorylating effectors (kinases) into host cells, which may have redundant or even antagonistic functions. The role of phosphorylation in disease is poorly understood, but in many other systems regulates how proteins interact.
I propose to show that EPEC's ability to manipulate phosphorylation of host proteins triggers dramatic changes in the way they behave and bind to each other, and that this is essential to infection. I first will use a newly developed technique to identify which host proteins are specifically phosphorylated by the effectors of EPEC, and which are phosphorylated as a general consequence of infection. I will then monitor how the interaction partnerships that host proteins participate in change as a consequence of this phosphorylation. Finally, I will investigate whether interfering in these EPEC-manipulation of host protein interaction blocks infection. This will be the first ever whole cell host-pathogen "interactome" study, and will develop a methodology for studying host-pathogen relationships, aiding development of better antibiotics in an age of increasing bacterial resistance.
Competitiondate
201611
Approvedterm2
2 yrs 0 mth
Pinamesdelim
McCoy, James M
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~